Combined chemoradiotherapy in small cell lung cancer

Hematology/Oncology Clinics of North America

Volumn 19, Issue 2, 2005, Pages 321-342

  Hahn, Noah M ^a   Hanna, Nasser ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; ESOPHAGITIS; ESOPHAGUS STRICTURE; HUMAN; LEUKOPENIA; LIVER TOXICITY; LUNG SMALL CELL CANCER; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; VOMITING;

EID: 17044428531     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2005.02.004     Document Type: Review

References (82)

1. American Cancer Society Cancer facts and figures 2004 2004 American Cancer Society, Inc. Atlanta (GA)
2. P. Warde, and P. Payne Does thoracic irradiation improve survival and local control in limited-stage small cell carcinoma of the lung? A meta-analysis J Clin Oncol 10 6 1992 890 895
3. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small cell lung cancer N Engl J Med 327 23 1992 1618 1624
4. G. Steel Terminology in the description of drug-radiation interactions Int J Radiat Oncol Biol Phys 5 8 1979 1145 1150
5. A.C. Begg Cisplatin and radiation: interaction probabilities and therapeutic possibilities Int J Radiat Oncol Biol Phys 19 5 1990 1183 1189
6. L.X. Yang, E.B. Douple, and J.A. O'Hara Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation Radiat Res 143 3 1995 309 315
7. E. Douple, and R. Richmond A review of platinum complex biochemistry suggests a rationale for combined platinum radiotherapy Int J Radiat Oncol Biol Phys 5 8 1979 1335 1339
8. K. Fu, P. Rayner, and K. Lam Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion Int J Radiat Oncol Biol Phys 10 8 1984 1477 1478
9. K.R. Hande Etoposide: four decades of development of a topoisomerase II inhibitor Eur J Can 34 10 1998 1514 1521
10. N. Giocanti, C. Hennequin, and J. Balosso Repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide Cancer Res 53 9 1993 2105 2111
11. M. Swartz, J. Roseman, and L. Gunderson Podophyllin increases tumor radioresponsiveness Cancer Chemo Pharm 7 1982 238 239
12. Y.Q. Yu, N. Giocanti, and D. Averbeck Radiation-induced arrest of cells in G2 phase elicits hypersensitivity to DNA double-strand break inducers and an altered pattern of DNA cleavage upon re-irradiation Int J Radiat Biol 76 7 2000 901 912
13. M.C. Perry, W.L. Eaton, and K.J. Propert Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung N Engl J Med 316 15 1987 912 918
14. N. Murray, P. Coy, and J.L. Pater Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer J Clin Oncol 11 2 1993 336 344
15. M. Takada, M. Fukuoka, and M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group study 9104 J Clin Oncol 20 14 2002 3054 3060
16. D.B. Fried, D.E. Morris, and C. Poole Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited stage small-cell lung cancer J Clin Oncol 22 23 2004 4837 4845
17. D.N. Carney, J.B. Mitchell, and T.J. Kinsella In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphologic variants Cancer Res 43 6 1983 2806 2811
18. B.E. Johnson, J.D. Bridges, and M. Sobczeck Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine J Clin Oncol 14 3 1996 806 813
19. B. Jeremic, Y. Shibamoto, and L. Acimovic Carboplatin, etoposide, and accelerated hyperfractionated radiotherapy for elderly patients with limited small cell lung carcinoma: a phase II study Cancer 82 5 1998 836 841
20. M.A. Ali, M.J. Kraut, and M. Valdivieso Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer Lung Cancer 22 1 1998 39 44
21. A. Hugli, D. Moro, and B. Mermillod Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer J Clin Oncol 18 8 2000 1662 1667
22. B. Mennecier, P. Jacoulet, and A. Dubiez Concurrent cisplatin/etoposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase II study Lung Cancer 27 3 2000 137 143
23. D.V. Skarlos, E. Samantas, and E. Briassoulis Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: a randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) Ann Oncol 12 9 2001 1231 1238
24. M. Arquette, T. Wasserman, and R. Govindan Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation Sem Rad Oncol 12 1 Suppl 1 2002 59 61
25. Y. Segawa, H. Ueoka, and K. Kiura Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer Lung Cancer 41 1 2003 13 20
26. J.A. Bonner, J.A. Sloan, and T.G. Shanahan Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma J Clin Oncol 17 9 1999 2681 2691
27. A.T. Turrisi, K. Kyungmann, and R. Blum Twice-daily compared with once-daily thoracic radiotherapy in limted small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 4 1999 265 271
28. N.C. Choi, J.E. Herndon, and J. Rosenman Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated- accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small cell lung cancer J Clin Oncol 16 11 1998 3528 3537
29. J.A. Bogart, J.E. Herndon, and A.P. Lyss 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B Study 39808 Int J Radiation Oncology Biophys 59 2 2004 460 468
30. P. Coy, I. Hodson, and D.G. Payne The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a Canadian Multicenter Randomized Trial Int J Radiat Oncol Biol Phys 14 2 1988 219 226
31. L.E. Gaspar, G.E. Gay, and J. Crawford Limited small cell lung cancer (stages I-III): observations from the National Cancer Database [abstract] Proc Am Soc Clin Oncol 2004 7042a
32. N. Murray, C. Grafton, and A. Shah Abbreviated treatment for elderly, infirm, or noncompliant patients with limited-stage small-cell lung cancer J Clin Oncol 16 10 1998 3323 3328
33. M.S. Kies, J.G. Mira, and J.J. Crowley Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group study J Clin Oncol 5 4 1987 592 600
34. V. Liengswangwong, J.A. Bonner, and E.G. Shaw Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy J Clin Oncol 12 3 1994 496 502
35. J.L. Pujol, L. Carestia, and J.P. Dauries Is there a case for cisplatin in the treatment of small cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agent Br J Cancer 83 1 2000 8 15
36. C. Mascaux, M. Paesmans, and T. Berghmans A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis Lung Cancer 30 1 2000 23 36
37. S.A. Laurie, D. Logan, and B.R. Markman Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care, practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer Lung Cancer 43 2 2004 223 240
38. D.V. Skarlos, E. Samantas, and P. Kosmidis Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study Ann Oncol 5 7 1994 601 607
39. D.F. Bajorin, M.F. Sarosdy, and D.G. Pfister Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study J Clin Oncol 11 4 1993 598 606
40. A. Horwich, D.T. Sleijfer, and S.D. Fossa Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial J Clin Oncol 15 5 1997 1844 1852
41. K. Hotta, K. Matsuo, and H. Ueoka Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer J Clin Oncol 22 19 2004 3852 3859
42. I.S. Woo, Y.S. Park, and S.H. Kwon A phase II study of VP-16-ifosfamide-cisplatin combination chemotherapy plus early concurrent thoracic irradiation for previously untreated limited small cell lung cancer Jpn J Clin Oncol 30 12 2000 542 546
43. S. Ishihara, S. Tsuchiya, and K. Minato A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer Am J Clin Oncol 23 2 2000 197 202
44. R.M. Bremnes, S. Sundstrom, and J. Vilsvik Multicenter phase II trial of paclitaxel, cisplatin, etoposide with concurrent radiation for limited-stage small-cell lung cancer J Clin Oncol 19 15 2001 3532 3538
45. C. Gridelli, C. Curcio, and R.V. Iaffaioli Carboplatin + epirubicin VP-16 + lenogastim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study Anticancer Res 21 6A 2001 4179 4184
46. K. Noda, Y. Nishiwaki, and M. Kawahara Irinotecan plus cisplatin compared to etoposide plus cisplatin for extensive small-cell lung cancer N Engl J Med 346 2 2002 85 91
47. S. Mitsuoka, S. Kudoh, and Y. Takada Phase II study of cisplatin, etoposide and concurrent thoracic radiotherapy (TRT) followed by irinotecan and cisplatin in patients with limited stage small-cell lung cancer (SCLC); updated results of WJTOG9902 [abstract] Proc Am Soc Clin Oncol 2004 7044a
48. E.E. Vokes, J.E. Herndon, and M.J. Kelley Induction chemotherapy followed by concomitant chemoradiotherapy (CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell lung cancer (NSCLC): initial analysis of a randomized phase III trial [abstract] Proc Am Soc Clin Oncol 2004 7005a
49. M. Viren, K. Liipo, A. Ojala, L. Helle, M. Jakobson, and M. Jarvinen Carboplatin and etoposide (CARE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer: a phase II study Acta Oncol 31 7 1992 761 765
50. C.R. Thomas, D.J. Giroux, and L.M. Janaki Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer Lung Cancer 33 2-3 2001 213 219
51. E. Maranzano, L. Crino, and F. Piro Long-term results of induction chemotherapy followed by concurrent chemotherapy and thoracic irradiation in limited small cell lung cancer Lung Cancer 37 1 2002 79 85
52. M.J. Edelman, K. Chansky, and L.E. Gaspar Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/ carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713 J Clin Oncol 22 1 2004 127 132
53. K. Kelly, J.J. Crowley, and P.A. Bunn Role of recombinant interferon Alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study J Clin Oncol 13 12 1995 2924 2930
54. K. Mattson, A. Niiranen, and T. Ruotsalainen Interferon maintenance therapy for small cell lung cancer improvement in long-term survival J Interfer Cyto Res 17 2 1997 103 105
55. R.A. Stahel, R.W. Takvorian, and A.T. Skarin Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature Eur J Can Clin Oncol 20 10 1984 1233 1238
56. A.M. Arnold, C.J. Williams, and G.M. Mead Combination chemotherapy using high or low dose methotrexate for small cell carcinoma of the lung-a randomized trial Med Oncol Tumor Pharm 1 1 1984 9 14
57. I.E. Smith, B.D. Evans, and S.J. Harland High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma Cancer Chem Pharm 14 2 1985 120 124
58. D. Cunningham, S.W. Banham, and A.H. Hutcheon High-dose cyclophosphamide and VP-16 as late dosage intensification therapy for small cell carcinoma of lung Cancer Chem Pharm 15 3 1985 303 306
59. C. Wilson, D. Pickering, and S. Stewart High dose chemotherapy with autologous bone marrow rescue in small cell lung cancer In Vivo 2 5 1988 331 334
60. M. Marangolo, G. Rosti, and D. Amadori High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study Bone Marrow Transplant 4 4 1989 405 408
61. G.E. Goodman, J. Crowley, and R.B. Livingston Treatment of limited small-cell lung cancer with concurrent etoposide/cisplatin and radiotherapy followed by intensification with high-dose cyclophosphamide: a Southwest Oncology Group study J Clin Oncol 9 3 1991 453 457
62. Y.H. Bao High dose chemotherapy with autologous bone marrow rescue for small cell lung cancer Chinese J Oncol 13 6 1992 452 455
63. R. Rosell, J. Carles, and A. Abad Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer Invest New Drugs 10 2 1992 123 128
64. A.D. Elias, L. Ayash, and E. Frei Intensive combined modality therapy for limited-stage small-cell lung cancer J Natl Cancer Inst 85 7 1993 559 566
65. W. Brugger, H. Frommhold, and K. Pressler Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer Semin Oncol 22 1 Suppl 2 1995 3 8
66. S. Fetscher, W. Brugger, and R. Engelhardt Dose-intensity therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer Ann Oncol 8 1 1997 49 56
67. S. Leyvraz, L. Perey, and G. Rosti Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgastim for small-cell lung cancer: a feasibility study by the European Group for Blood and Marrow Transplantation J Clin Oncol 17 11 1999 3531 3539
68. A. Bessho, H. Ueoka, and K. Kiura High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer Anticancer Res 19 1B 1999 693 698
69. J.M. Tourani, C. Jaillon-Abraham, and Y. Coscas Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma-results of three consecutive phase II programs Acta Oncol 39 4 2000 501 508
70. J.D. Rizzo, A.D. Elias, and P.J. Stiff Autologous stem cell transplantation for small cell lung cancer Biol Blood Mar Transpl 8 5 2002 273 280
71. E. Oelmann, M. Thomas, and H. Serve Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase I/II trial Oncology 63 3 2002 248 253
72. F. Pasini, E. Durante, and D. De Manzoni High-dose chemotherapy in small-cell lung cancer Anticancer Res 22 6B 2002 3465 3472
73. P.A. Bunn, J. Crowley, and K. Kelley Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group J Clin Oncol 13 7 1995 1632 1641
74. S.M. Lee, L.E. James, and V. Mohamed-Ali A phase II study of carboplatin/etoposide with thalidomide in small cell lung cancer (SCLC) [abstract] Proc Am Soc Clinc Oncol 2002 1251a
75. M.A. Socinski, C. Weissman, and L.L. Hart Randomized phase II trial of pemetrexed with either cisplatin or carboplatin in extensive stage small cell lung cancer [abstract] Proc Am Soc Clin Oncol 2004 7204a
76. F.A. Shepherd, G. Giaccone, and L. Seymour Trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer J Clin Oncol 20 22 2002 4434 4439
77. J.R. Rigas, C.A. Denham, and D.A. Rinaldi Randomized placebo-controlled trials of the matrix metalloproteinase inhibitor (MMPI), BAY12-9566 as adjuvant therapy for patients with small cell and non-small cell lung cancer [abstract] Proc Am Soc Clin Oncol 2003 2525a
78. S.C. Grant, M.G. Kris, and V. Miller Long survival in 15 (pts) with small cell lung cancer (SCLC) immunized with BEC2 plus BCG after initial therapy: an update [abstract] Proc Am Soc Clin Oncol 1997 1630a
79. G. Giaccone, C. Debruyne, and E. Felip Phase III study of BEC2/BCG vaccination in limited disease small cell lung cancer (LD-SCLC) patients, following response to chemotherapy and thoracic irradiation (EORTC 08971, the SILVA study) [abstract] Proc Am Soc Clin Oncol 2004 7020a
80. Q.T. Le, J. McCoy, and S. Williamson Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study Clin Cancer Res 10 16 2004 5418 5424
81. C.M. Rudin, M. Kozloff, and P.C. Hoffman Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small cell lung cancer J Clin Oncol 22 6 2004 1110 1117
82. B.E. Johnson, T. Fischer, and B. Fischer Phase II study of imatinib in patients with small cell lung cancer Clin Cancer Res 9 16 Pt 1 2003 5880 5887